New insights into VacA intoxication mediated through its cell surface receptors

Toxins

Volumn 8, Issue 5, 2016, Pages

  Yahiro, Kinnosuke ^a   Hirayama, Toshiya ^b   Moss, Joel ^c   Noda, Masatoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Low density lipoprotein receptor related protein 1 (LRP1); Receptor like protein tyrosine phosphatase (RPTP) ; Receptors; RPTP ; Vacuolating cytotoxin (VacA)

Indexed keywords

CELL SURFACE RECEPTOR; FIBRONECTIN; LIPOPOLYSACCHARIDE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; VACUOLATING TOXIN; BACTERIAL PROTEIN; VACA PROTEIN, HELICOBACTER PYLORI;

APOPTOSIS; AUTOPHAGY; CELL PROLIFERATION; HELICOBACTER PYLORI; HUMAN; IMMUNOPRECIPITATION; INFLAMMATION; INTOXICATION; PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; ULCER; ANIMAL; METABOLISM;

ANIMALS; BACTERIAL PROTEINS; HUMANS; RECEPTORS, CELL SURFACE;

EID: 84969135728     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins8050152     Document Type: Review

References (100)

1. Montecucco, C.; Rappuoli, R. Living dangerously: How Helicobacter pylori survives in the human stomach. Nat. Rev. Mol. Cell Biol. 2001, 2, 457-466. [CrossRef] [PubMed]
2. Suzuki, T.; Matsushima, M.; Shirakura, K.; Koike, J.; Masui, A.; Takagi, A.; Shirasugi, Y.; Ogawa, Y.; Shirai, T.; Mine, T. Association of inflammatory cytokine gene polymorphisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori. Digestion 2008, 77, 73-78. [CrossRef] [PubMed]
3. Blaser, M.J.; Atherton, J.C. Helicobacter pylori persistence: Biology and disease. J. Clin. Investig. 2004, 113, 321-333. [CrossRef] [PubMed]
4. Algood, H.M.; Cover, T.L. Helicobacter pylori persistence: An overview of interactions between H. pylori and host immune defenses. Clin. Microbiol. Rev. 2006, 19, 597-613. [CrossRef] [PubMed]
5. Suerbaum, S.; Michetti, P. Helicobacter pylori infection. N. Engl. J. Med. 2002, 347, 1175-1186. [CrossRef] [PubMed]
6. Pagliaccia, C.; de Bernard, M.; Lupetti, P.; Ji, X.; Burroni, D.; Cover, T.L.; Papini, E.; Rappuoli, R.; Telford, J.L.; Reyrat, J.M. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl. Acad. Sci. USA 1998, 95, 10212-10217. [CrossRef] [PubMed]
7. Reyrat, J.M.; Lanzavecchia, S.; Lupetti, P.; de Bernard, M.; Pagliaccia, C.; Pelicic, V.; Charrel, M.; Ulivieri, C.; Norais, N.; Ji, X.; et al. 3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin. J. Mol. Biol. 1999, 290, 459-470. [CrossRef] [PubMed]
8. Wang, W.C.; Wang, H.J.; Kuo, C.H. Two distinctive cell binding patterns by vacuolating toxin fused with glutathione S-transferase: One high-affinity m1-specific binding and the other lower-affinity binding for variant m forms. Biochemistry 2001, 40, 11887-11896. [CrossRef] [PubMed]
9. De Bernard, M.; Burroni, D.; Papini, E.; Rappuoli, R.; Telford, J.; Montecucco, C. Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol. Infect. Immun. 1998, 66, 6014-6016. [PubMed]
10. Ye, D.; Willhite, D.C.; Blanke, S.R. Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin. J. Biol. Chem. 1999, 274, 9277-9282. [CrossRef] [PubMed]
11. Ghose, C.; Perez-Perez, G.I.; Torres, V.J.; Crosatti, M.; Nomura, A.; Peek, R.M., Jr.; Cover, T.L.; Francois, F.; Blaser, M.J. Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2. Clin. Vaccine Immunol. CVI 2007, 14, 442-450. [CrossRef] [PubMed]
12. Skibinski, D.A.; Genisset, C.; Barone, S.; Telford, J.L. The cell-specific phenotype of the polymorphic VacA midregion is independent of the appearance of the cell surface receptor protein tyrosine phosphatase beta. Infect. Immun. 2006, 74, 49-55. [CrossRef] [PubMed]
13. Gangwer, K.A.; Mushrush, D.J.; Stauff, D.L.; Spiller, B.; McClain, M.S.; Cover, T.L.; Lacy, D.B. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain. Proc. Natl. Acad. Sci. USA 2007, 104, 16293-16298. [CrossRef] [PubMed]
14. De Guzman, B.B.; Hisatsune, J.; Nakayama, M.; Yahiro, K.;Wada, A.; Yamasaki, E.; Nishi, Y.; Yamazaki, S.; Azuma, T.; Ito, Y.; et al. Cytotoxicity and recognition of receptor-like protein tyrosine phosphatases, rptpalpha and rptpbeta, by Helicobacter pylori m2 VacA. Cell. Microbiol. 2005, 7, 1285-1293. [CrossRef] [PubMed]
15. Wang, H.J.; Kuo, C.H.; Yeh, A.A.; Chang, P.C.;Wang,W.C. Vacuolating toxin production in clinical isolates of Helicobacter pylori with different VacA genotypes. J. Infect. Dis. 1998, 178, 207-212. [CrossRef] [PubMed]
16. Cover, T.L.; Blaser, M.J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 1992, 267, 10570-10575. [PubMed]
17. Cover, T.L.; Blanke, S.R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 2005, 3, 320-332. [CrossRef] [PubMed]
18. Palframan, S.L.; Kwok, T.; Gabriel, K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front. Cell. Infect. Microbiol. 2012, 2. [CrossRef] [PubMed]
19. Cid, T.P.; Fernandez, M.C.; Benito Martinez, S.; Jones, N.L. Pathogenesis of Helicobacter pylori infection. Helicobacter 2013, 18 (Suppl. 1), 12-17. [CrossRef] [PubMed]
20. Greenfield, L.K.; Jones, N.L. Modulation of autophagy by Helicobacter pylori and its role in gastric carcinogenesis. Trends Microbiol. 2013, 21, 602-612. [CrossRef] [PubMed]
21. Boquet, P.; Ricci, V. Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol. 2012, 20, 165-174. [CrossRef] [PubMed]
22. Rassow, J. Helicobacter pylori vacuolating toxin A and apoptosis. Cell Commun. Signal. CCS 2011, 9. [CrossRef] [PubMed]
23. Kim, I.J.; Blanke, S.R. Remodeling the host environment: Modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Front. Cell. Infect. Microbiol. 2012, 2. [CrossRef] [PubMed]
24. Terebiznik, M.R.; Raju, D.; Vazquez, C.L.; Torbricki, K.; Kulkarni, R.; Blanke, S.R.; Yoshimori, T.; Colombo, M.I.; Jones, N.L. Effect of Helicobacter pylori’s vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy 2009, 5, 370-379. [CrossRef] [PubMed]
25. Telford, J.L.; Ghiara, P.; Dell’Orco, M.; Comanducci, M.; Burroni, D.; Bugnoli, M.; Tecce, M.F.; Censini, S.; Covacci, A.; Xiang, Z.; et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 1994, 179, 1653-1658. [CrossRef] [PubMed]
26. Tombola, F.; Carlesso, C.; Szabo, I.; de Bernard, M.; Reyrat, J.M.; Telford, J.L.; Rappuoli, R.; Montecucco, C.; Papini, E.; Zoratti, M. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: Possible implications for the mechanism of cellular vacuolation. Biophys. J. 1999, 76, 1401-1409. [CrossRef]
27. Szabo, I.; Brutsche, S.; Tombola, F.; Moschioni, M.; Satin, B.; Telford, J.L.; Rappuoli, R.; Montecucco, C.; Papini, E.; Zoratti, M. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J. 1999, 18, 5517-5527. [CrossRef] [PubMed]
28. Yahiro, K.; Satoh, M.; Nakano, M.; Hisatsune, J.; Isomoto, H.; Sap, J.; Suzuki, H.; Nomura, F.; Noda, M.; Moss, J.; et al. Low-density lipoprotein receptor-related protein-1 (LRP1) mediates autophagy and apoptosis caused by Helicobacter pylori VacA. J. Biol. Chem. 2012, 287, 31104-31115. [CrossRef] [PubMed]
29. Yahiro, K.; Niidome, T.; Kimura, M.; Hatakeyama, T.; Aoyagi, H.; Kurazono, H.; Imagawa, K.; Wada, A.; Moss, J.; Hirayama, T. Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. J. Biol. Chem. 1999, 274, 36693-36699. [CrossRef] [PubMed]
30. Haunso, A.; Celio, M.R.; Margolis, R.K.; Menoud, P.A. Phosphacan immunoreactivity is associated with perineuronal nets around parvalbumin-expressing neurones. Brain Res. 1999, 834, 219-222. [CrossRef]
31. Maeda, N.; Nishiwaki, T.; Shintani, T.; Hamanaka, H.; Noda, M. 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J. Biol. Chem. 1996, 271, 21446-21452. [PubMed]
32. Meyer-Puttlitz, B.; Junker, E.; Margolis, R.U.; Margolis, R.K. Chondroitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan. J. Comp. Neurol. 1996, 366, 44-54. [CrossRef]
33. Yuki, T.; Ishihara, S.; Rumi, M.; Ortega-Cava Cesar, F.; Kadowaki, Y.; Kazumori, H.; Yuki, M.; Wada, T.; Miyaoka, Y.; Yoshino, N.; et al. Expression of midkine and receptor-like protein tyrosine phosphatase (RPTP)-beta genes in the rat stomach and the influence of rebamipide. Aliment. Pharmacol. Ther. 2003, 18 (Suppl. 1), 106-112. [CrossRef] [PubMed]
34. Fujikawa, A.; Shirasaka, D.; Yamamoto, S.; Ota, H.; Yahiro, K.; Fukada, M.; Shintani, T.;Wada, A.; Aoyama, N.; Hirayama, T.; et al. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat. Genet. 2003, 33, 375-381. [CrossRef] [PubMed]
35. Carr, A.N.; Davis, M.G.; Eby-Wilkens, E.; Howard, B.W.; Towne, B.A.; Dufresne, T.E.; Peters, K.G. Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease. Am. J. Physiol. Heart Circ. Physiol. 2004, 287, H268-H276. [CrossRef] [PubMed]
36. Dominguez, M.G.; Hughes, V.C.; Pan, L.; Simmons, M.; Daly, C.; Anderson, K.; Noguera-Troise, I.; Murphy, A.J.; Valenzuela, D.M.; Davis, S.; et al. Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc. Natl. Acad. Sci. USA 2007, 104, 3243-3248. [CrossRef] [PubMed]
37. Baumer, S.; Keller, L.; Holtmann, A.; Funke, R.; August, B.; Gamp, A.;Wolburg, H.;Wolburg-Buchholz, K.; Deutsch, U.; Vestweber, D. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 2006, 107, 4754-4762. [CrossRef] [PubMed]
38. De Bernard, M.; Moschioni, M.; Papini, E.; Telford, J.L.; Rappuoli, R.; Montecucco, C. Tpa and butyrate increase cell sensitivity to the vacuolating toxin of Helicobacter pylori. FEBS Lett. 1998, 436, 218-222. [CrossRef]
39. Padilla, P.I.;Wada, A.; Yahiro, K.; Kimura, M.; Niidome, T.; Aoyagi, H.; Kumatori, A.; Anami, M.; Hayashi, T.; Fujisawa, J.; et al. Morphologic differentiation of HL-60 cells is associated with appearance of RPTPbeta and induction of Helicobacter pylori VacA sensitivity. J. Biol. Chem. 2000, 275, 15200-15206. [CrossRef] [PubMed]
40. Yahiro, K.; Wada, A.; Yamasaki, E.; Nakayama, M.; Nishi, Y.; Hisatsune, J.; Morinaga, N.; Sap, J.; Noda, M.; Moss, J.; et al. Essential domain of receptor tyrosine phosphatase beta (RPTPbeta) for interaction with Helicobacter pylori vacuolating cytotoxin. J. Biol. Chem. 2004, 279, 51013-51021. [CrossRef] [PubMed]
41. Hammer, A.; Oladimeji, P.; De Las Casas, L.E.; Diakonova, M. Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover. FASEB J. 2015, 29, 943-959. [CrossRef] [PubMed]
42. Matthews, R.J.; Cahir, E.D.; Thomas, M.L. Identification of an additional member of the protein-tyrosine-phosphatase family: Evidence for alternative splicing in the tyrosine phosphatase domain. Proc. Natl. Acad. Sci. USA 1990, 87, 4444-4448. [CrossRef] [PubMed]
43. Sap, J.; D’Eustachio, P.; Givol, D.; Schlessinger, J. Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 1990, 87, 6112-6116. [CrossRef] [PubMed]
44. Yahiro, K.; Wada, A.; Nakayama, M.; Kimura, T.; Ogushi, K.; Niidome, T.; Aoyagi, H.; Yoshino, K.; Yonezawa, K.; Moss, J.; et al. Protein-tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J. Biol. Chem. 2003, 278, 19183-19189. [CrossRef] [PubMed]
45. Truffi, M.; Dubreuil, V.; Liang, X.; Vacaresse, N.; Nigon, F.; Han, S.P.; Yap, A.S.; Gomez, G.A.; Sap, J. RPTPalpha controls epithelial adherens junctions, linking E-cadherin engagement to c-Src-mediated phosphorylation of cortactin. J. Cell Sci. 2014, 127, 2420-2432. [CrossRef] [PubMed]
46. Gomez, G.A.; McLachlan, R.W.; Wu, S.K.; Caldwell, B.J.; Moussa, E.; Verma, S.; Bastiani, M.; Priya, R.; Parton, R.G.; Gaus, K.; et al. An RPTPalpha/Src family kinase/RAP1 signaling module recruits myosin IIB to support contractile tension at apical E-cadherin junctions. Mol. Biol. Cell 2015, 26, 1249-1262. [CrossRef] [PubMed]
47. Hussain, M.M.; Strickland, D.K.; Bakillah, A. The mammalian low-density lipoprotein receptor family. Ann. Rev. Nutr. 1999, 19, 141-172. [CrossRef] [PubMed]
48. Raju, D.; Hussey, S.; Ang, M.; Terebiznik, M.R.; Sibony, M.; Galindo-Mata, E.; Gupta, V.; Blanke, S.R.; Delgado, A.; Romero-Gallo, J.; et al. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 2012, 142, 1160-1171. [CrossRef] [PubMed]
49. Cover, T.L.; Krishna, U.S.; Israel, D.A.; Peek, R.M., Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 2003, 63, 951-957. [PubMed]
50. Willhite, D.C.; Blanke, S.R. Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell. Microbiol. 2004, 6, 143-154. [CrossRef] [PubMed]
51. Yamasaki, E.; Wada, A.; Kumatori, A.; Nakagawa, I.; Funao, J.; Nakayama, M.; Hisatsune, J.; Kimura, M.; Moss, J.; Hirayama, T. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins bax and bak, leading to cytochrome c release and cell death, independent of vacuolation. J. Biol. Chem. 2006, 281, 11250-11259. [CrossRef] [PubMed]
52. Kuck, D.; Kolmerer, B.; Iking-Konert, C.; Krammer, P.H.; Stremmel, W.; Rudi, J. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line ags. Infect. Immun. 2001, 69, 5080-5087. [CrossRef] [PubMed]
53. Galmiche, A.; Rassow, J.; Doye, A.; Cagnol, S.; Chambard, J.C.; Contamin, S.; de Thillot, V.; Just, I.; Ricci, V.; Solcia, E.; et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J. 2000, 19, 6361-6370. [CrossRef] [PubMed]
54. Tombola, F.; Oregna, F.; Brutsche, S.; Szabo, I.; Del Giudice, G.; Rappuoli, R.; Montecucco, C.; Papini, E.; Zoratti, M. Inhibition of the vacuolating and anion channel activities of the VacA toxin of Helicobacter pylori. FEBS Lett. 1999, 460, 221-225. [CrossRef]
55. Jain, P.; Luo, Z.Q.; Blanke, S.R. Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc. Natl. Acad. Sci. USA 2011, 108, 16032-16037. [CrossRef] [PubMed]
56. Radin, J.N.; Gonzalez-Rivera, C.; Ivie, S.E.; McClain, M.S.; Cover, T.L. Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect. Immun. 2011, 79, 2535-2543. [CrossRef] [PubMed]
57. Hatakeyama, M. Helicobacter pylori caga and gastric cancer: A paradigm for hit-and-run carcinogenesis. Cell Host Microbe 2014, 15, 306-316. [CrossRef] [PubMed]
58. Tsugawa, H.; Suzuki, H.; Saya, H.; Hatakeyama, M.; Hirayama, T.; Hirata, K.; Nagano, O.; Matsuzaki, J.; Hibi, T. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe 2012, 12, 764-777. [CrossRef] [PubMed]
59. Seto, K.; Hayashi-Kuwabara, Y.; Yoneta, T.; Suda, H.; Tamaki, H. Vacuolation induced by cytotoxin from Helicobacter pylori is mediated by the EGF receptor in hela cells. FEBS Lett. 1998, 431, 347-350. [CrossRef]
60. Tabel, G.; Hoa, N.T.; Tarnawski, A.; Chen, J.; Domek, M.; Ma, T.Y. Helicobacter pylori infection inhibits healing of the wounded duodenal epithelium in vitro. J. Lab. Clin. Med. 2003, 142, 421-430. [CrossRef] [PubMed]
61. Tegtmeyer, N.; Zabler, D.; Schmidt, D.; Hartig, R.; Brandt, S.; Backert, S. Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori caga protein: Antagonistic effects of the vacuolating cytotoxin VacA. Cell. Microbiol. 2009, 11, 488-505. [CrossRef] [PubMed]
62. Bradshaw, M.J.; Smith, M.L. Multiscale relationships between fibronectin structure and functional properties. Acta Biomater. 2014, 10, 1524-1531. [PubMed]
63. Schwarz-Linek, U.; Werner, J.M.; Pickford, A.R.; Gurusiddappa, S.; Kim, J.H.; Pilka, E.S.; Briggs, J.A.; Gough, T.S.; Hook, M.; Campbell, I.D.; et al. Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper. Nature 2003, 423, 177-181. [CrossRef] [PubMed]
64. Gruenheid, S.; Finlay, B.B. Microbial pathogenesis and cytoskeletal function. Nature 2003, 422, 775-781. [PubMed]
65. Hennig, E.E.; Godlewski, M.M.; Butruk, E.; Ostrowski, J. Helicobacter pylori VacA cytotoxin interacts with fibronectin and alters hela cell adhesion and cytoskeletal organization in vitro. FEMS Immunol. Med. Microbiol. 2005, 44, 143-150. [CrossRef] [PubMed]
66. Pai, R.; Cover, T.L.; Tarnawski, A.S. Helicobacter pylori vacuolating cytotoxin (VacA) disorganizes the cytoskeletal architecture of gastric epithelial cells. Biochem. Biophys. Res. Commun. 1999, 262, 245-250. [CrossRef] [PubMed]
67. Utt, M.; Danielsson, B.; Wadstrom, T. Helicobacter pylori vacuolating cytotoxin binding to a putative cell surface receptor, heparan sulfate, studied by surface plasmon resonance. FEMS Immunol. Med. Microbiol. 2001, 30, 109-113. [CrossRef] [PubMed]
68. Dedieu, S.; Langlois, B. Lrp-1: A new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells. Cell Adhes. Migr. 2008, 2, 77-80. [CrossRef]
69. Geisse, N.A.; Cover, T.L.; Henderson, R.M.; Edwardson, J.M. Targeting of Helicobacter pylori vacuolating toxin to lipid raft membrane domains analysed by atomic force microscopy. Biochem. J. 2004, 381, 911-917. [CrossRef] [PubMed]
70. Schraw,W.; Li, Y.; McClain, M.S.; van der Goot, F.G.; Cover, T.L. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J. Biol. Chem. 2002, 277, 34642-34650. [CrossRef] [PubMed]
71. Patel, H.K.; Willhite, D.C.; Patel, R.M.; Ye, D.; Williams, C.L.; Torres, E.M.; Marty, K.B.; MacDonald, R.A.; Blanke, S.R. Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin. Infect. Immun. 2002, 70, 4112-4123. [CrossRef] [PubMed]
72. Kuo, C.H.; Wang, W.C. Binding and internalization of Helicobacter pylori VacA via cellular lipid rafts in epithelial cells. Biochem. Biophys. Res. Commun. 2003, 303, 640-644. [CrossRef]
73. Nakayama, M.; Hisatsune, J.; Yamasaki, E.; Nishi, Y.;Wada, A.; Kurazono, H.; Sap, J.; Yahiro, K.; Moss, J.; Hirayama, T. Clustering of Helicobacter pylori VacA in lipid rafts, mediated by its receptor, receptor-like protein tyrosine phosphatase beta, is required for intoxication in AZ-521 cells. Infect. Immun. 2006, 74, 6571-6580. [CrossRef] [PubMed]
74. Pike, L.J. Lipid rafts: Bringing order to chaos. J. Lipid Res. 2003, 44, 655-667. [CrossRef] [PubMed]
75. Ricci, V.; Galmiche, A.; Doye, A.; Necchi, V.; Solcia, E.; Boquet, P. High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. Mol. Biol. Cell 2000, 11, 3897-3909. [CrossRef] [PubMed]
76. Gupta, V.R.; Patel, H.K.; Kostolansky, S.S.; Ballivian, R.A.; Eichberg, J.; Blanke, S.R. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog. 2008, 4, e1000073. [CrossRef] [PubMed]
77. Czajkowsky, D.M.; Iwamoto, H.; Cover, T.L.; Shao, Z. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low ph. Proc. Natl. Acad. Sci. USA 1999, 96, 2001-2006. [CrossRef] [PubMed]
78. Gupta, V.R.;Wilson, B.A.; Blanke, S.R. Sphingomyelin is important for the cellular entry and intracellular localization of Helicobacter pylori VacA. Cell. Microbiol. 2010, 12, 1517-1533. [CrossRef] [PubMed]
79. Sasisekharan, R.; Venkataraman, G. Heparin and heparan sulfate: Biosynthesis, structure and function. Curr. Opin. Chem. Biol. 2000, 4, 626-631. [CrossRef]
80. Sommi, P.; Ricci, V.; Romano, M.; Fiocca, R.; Ivey, K.J.; Solcia, E.; Ventura, U. H-pylori-induced cell vacuolation in vitro: Inhibitory action of heparin. Gastroenterology 1997, 112, A294-A294.
81. Maeda, N.; Ichihara-Tanaka, K.; Kimura, T.; Kadomatsu, K.; Muramatsu, T.; Noda, M. A receptor-like protein-tyrosine phosphatase ptpzeta/rptpbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to ptpzeta. J. Biol. Chem. 1999, 274, 12474-12479. [CrossRef] [PubMed]
82. Molinari, M.; Salio, M.; Galli, C.; Norais, N.; Rappuoli, R.; Lanzavecchia, A.; Montecucco, C. Selective inhibition of ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 1998, 187, 135-140. [CrossRef] [PubMed]
83. Torres, V.J.; vanCompernolle, S.E.; Sundrud, M.S.; Unutmaz, D.; Cover, T.L. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J. Immunol. 2007, 179, 5433-5440. [CrossRef] [PubMed]
84. Gebert, B.; Fischer,W.;Weiss, E.; Hoffmann, R.; Haas, R. Helicobacter pylori vacuolating cytotoxin inhibits t lymphocyte activation. Science 2003, 301, 1099-1102. [CrossRef] [PubMed]
85. Boncristiano, M.; Paccani, S.R.; Barone, S.; Ulivieri, C.; Patrussi, L.; Ilver, D.; Amedei, A.; D’Elios, M.M.; Telford, J.L.; Baldari, C.T. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 2003, 198, 1887-1897. [CrossRef] [PubMed]
86. Sundrud, M.S.; Torres, V.J.; Unutmaz, D.; Cover, T.L. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. USA 2004, 101, 7727-7732. [CrossRef] [PubMed]
87. Sewald, X.; Gebert-Vogl, B.; Prassl, S.; Barwig, I.;Weiss, E.; Fabbri, M.; Osicka, R.; Schiemann, M.; Busch, D.H.; Semmrich, M.; et al. Integrin subunit CD18 is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe 2008, 3, 20-29. [CrossRef] [PubMed]
88. Sewald, X.; Jimenez-Soto, L.; Haas, R. Pkc-dependent endocytosis of the Helicobacter pylori vacuolating cytotoxin in primary T lymphocytes. Cell. Microbiol. 2011, 13, 482-496. [CrossRef] [PubMed]
89. Gonzalez-Rivera, C.; Algood, H.M.; Radin, J.N.; McClain, M.S.; Cover, T.L. The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a jurkat T cell assay. Infect. Immun. 2012, 80, 2578-2588. [CrossRef] [PubMed]
90. Rhead, J.L.; Letley, D.P.; Mohammadi, M.; Hussein, N.; Mohagheghi, M.A.; Eshagh Hosseini, M.; Atherton, J.C. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007, 133, 926-936. [CrossRef] [PubMed]
91. Kim, J.M.; Kim, J.S.; Yoo, D.Y.; Ko, S.H.; Kim, N.; Kim, H.; Kim, Y.J. Stimulation of dendritic cells with Helicobacter pylori vacuolating cytotoxin negatively regulates their maturation via the restoration of E2F1. Clin. Exp. Immunol. 2011, 166, 34-45. [CrossRef] [PubMed]
92. Elizalde, J.I.; Gomez, J.; Panes, J.; Lozano, M.; Casadevall, M.; Ramirez, J.; Pizcueta, P.; Marco, F.; Rojas, F.D.; Granger, D.N.; et al. Platelet activation in mice and human Helicobacter pylori infection. J. Clin. Investig. 1997, 100, 996-1005. [CrossRef] [PubMed]
93. Ahn, E.R.; Tiede, M.P.; Jy, W.; Bidot, C.J.; Fontana, V.; Ahn, Y.S. Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: Eradication reduces platelet activation but seldom improves platelet counts. Acta Haematol. 2006, 116, 19-24. [CrossRef] [PubMed]
94. Massaguer, A.; Engel, P.; Perez-del-Pulgar, S.; Bosch, J.; Pizcueta, P. Production and characterization of monoclonal antibodies against conserved epitopes of P-selectin (CD62P). Tissue Antigens 2000, 56, 117-128. [CrossRef] [PubMed]
95. Satoh, K.; Hirayama, T.; Takano, K.; Suzuki-Inoue, K.; Sato, T.; Ohta, M.; Nakagomi, J.; Ozaki, Y. VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets. Thromb. J. 2013, 11, 23. [CrossRef] [PubMed]
96. Stanley, P. Golgi glycosylation. Cold Spring Harb. Perspect. Biol. 2011, 3, 1-13. [CrossRef] [PubMed]
97. Lewandrowski, U.; Moebius, J.; Walter, U.; Sickmann, A. Elucidation of N-glycosylation sites on human platelet proteins: A glycoproteomic approach. Mol. Cell. Proteom. MCP 2006, 5, 226-233. [CrossRef] [PubMed]
98. Jeimy, S.B.; Fuller, N.; Tasneem, S.; Segers, K.; Stafford, A.R.; Weitz, J.I.; Camire, R.M.; Nicolaes, G.A.; Hayward, C.P. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation. Thromb. Haemost. 2008, 100, 1058-1067. [CrossRef] [PubMed]
99. Tasneem, S.; Adam, F.; Minullina, I.; Pawlikowska, M.; Hui, S.K.; Zheng, S.; Miller, J.L.; Hayward, C.P. Platelet adhesion to multimerin 1 in vitro: Influences of platelet membrane receptors, von willebrand factor and shear. J. Thromb. Haemost. JTH 2009, 7, 685-692. [CrossRef] [PubMed]
100. Karlsson, K.A. Microbial recognition of target-cell glycoconjugates. Curr. Opin. Struct. Biol. 1995, 5, 622-635. [CrossRef]